Ralf Mekle1, Jochen B. Fiebach1, and Heiner Stuke2
1Center for Stroke Research Berlin, Charité – Universitätsmedizin Berlin, Berlin, Germany, 2Department of Psychiatry and Psychotherapy, Charité – Universitätsmedizin Berlin, Berlin, Germany
Synopsis
The neurophysiological and neurochemical alterations
involved in the formation of hallucinations are not sufficiently understood.
fMRI was used during a face detection task, and neurotransmitter levels in the
visual cortex were measured by 1H
MRS at 3T to elucidate processes involved in the false (hallucinatory)
detection of faces in pure noise patterns. Increased hallucinatory face
detections were related to decreased activation of the fusiform face area. In
addition, decreased face-dependent activation was related to reduced glutamate
levels. These findings substantiate theories of hallucinatory misperceptions,
which implicate impaired glutamatergic transmission in a reduced ability to
differentiate between meaningful information and noise.
Introduction
Schizophrenia is a serious mental illness with poorly
understood etiology1.
Disease manifestations comprise among others psychotic symptoms, such as
delusions and hallucinations. The "Psychosis Continuum" theory
postulates that clinical manifestations of psychosis represent the most extreme
form of psychosis proneness, which is relatively continuously distributed in
the general population2.
Importantly, it implies similar etiological mechanisms involved in the
formation of subclinical and clinical psychotic symptoms. Hence, the
investigation of mechanisms involved in psychotic symptoms in non-patient
populations might contribute to explaining clinical symptoms as well. A
subclinical hallucination proneness has been assessed with tasks measuring the
tendency to detect meaning in noise stimuli. Here, schizophrenia patients,
particularly those having hallucinations, show an increased tendency to
recognize meaningful information in noise3, 4.
Moreover, increased detection in noise has been related to trait hallucination
proneness assessed by questionnaires in non-clinical populations5,6. Despite intense research
efforts, the neurochemical and neurofunctional underpinnings of hallucinations
are not sufficiently understood. Increased dopaminergic and reduced
glutamatergic neurotransmission have been hypothesized based on an abundancy of
experimental designs including postmortem pathological examination,
pharmacological challenging, PET, and magnetic resonance spectroscopy (MRS)7. In
this study, functional MRI (fMRI) and MRS were used to identify correlates of
hallucination proneness in healthy individuals.Methods
Subjects and Hardware: Eighteen subjects (aged 25 – 48 yrs,
11 f) were included (two subjects did not have MRS measurements for technical
reasons). Scans were performed on a 3T Trio system (Siemens Healthineers,
Erlangen, Germany) using a 32 channel radiofrequency (RF) coil
(N = 9), and after an upgrade on a 3T PrismaFit system employing a 64
channel RF coil (N = 9).
MRS: 1H MRS
was performed as described previously8 including localized
RF calibration and vendor-supplied shimming. Single volume spectra from the
right visual cortex were acquired using the MEGA-PRESS technique9 (VOI = 20x30x20 mm, TR/TE = 3000/68 ms, number of averages = 128, Tacq = 1024
ms, and editing pulse at 1.9 ppm). The FID-A toolkit10 was used for
pre-processing of MRS data. Resulting spectra were analyzed using LCModel11 with a simulated
basis set.
Face task: To quantify psychosis-like
mispercepts of illusory faces in noise, a face detection task that required the
participants to detect faces embedded in noise was devised6. The face task comprised 9 runs
each with 40 stimuli, of which 20 contained a face and 20 contained no face
(noise patterns only). Stimuli were presented for 4000 ms. After that,
participants were instructed to indicate if they had recognized a face (2000
ms) followed by an inter-trial-interval (fixation cross) jittered around 2500
ms. The percentage of false alarms (detection of faces in pure noise) was
computed as a measure of hallucination proneness.
FMRI acquisition and analysis: During the face task, functional images
were recorded using single-shot gradient-echo EPI (TR = 2250 ms, TE = 25
ms, voxel size = 2.5 mm isotropic). Preprocessing and analysis were
performed using the statistical parametric mapping (SPM12) software.
Preprocessing comprised slice timing, SPM12 standard realignment and unwarping
including field map correction, co-registration, normalization to MNI space,
and spatial smoothing. On single subject level, brain activation differences
related to presence of faces in the stimuli were analyzed using a general
linear model. The blood oxygen level dependent response was modeled by a
canonical hemodynamic response function for face cues, no face cues and
button-presses and ratings as noise regressors. The resulting t-statistic
images with face-dependent effects (face cues versus no face cues) were
submitted to group level analysis. At group level, main effects of face versus
no face were were tested. In addition, correlations between neurotransmitter
levels assessed by MRS and face-dependent effects in fMRI as well as
correlations between false alarms in the face task and face-dependent effects
were evaluated. For small volume correction of significance levels with family
wise error (FWE), a ROI of the bilateral gyrus fusiformis (face area) was used.Results
Shimming resulted in water linewidths of 7.1 ± 0.6
Hz across all MRS scans. Analysis
of MEGA-PRESS difference spectra (Fig. 1) allowed quantification of
neurotransmitters GABA, glutamate (Glu), glutathione (GSH), and combined Glu + glutamine
(Gln) with respect to N-acetylaspartate (NAA) (Table 1). Evaluating fMRI data
revealed that stimuli with faces compared to
those without faces led to significantly increased activation in the gyrus
fusiformis known to be a face-processing area (Fig. 2a). The magnitude of this
face-dependent activation was decreased in individuals with more false alarms (hallucination
proneness) in the face task (Fig. 2b). Importantly, decreased Glu/NAA ratios in
the right visual cortex were also associated with decreased face-dependent
activation (Fig. 2c). No correlation of fMRI results with GABA was found.Discussion
In this study, neurochemical and neurofunctional
correlates of visual hallucination proneness (defined as an increased readiness
to detect faces in pure noise patterns) were investigated. Decreased
face-dependent fMRI activation in the fusiform face area (FFA) was associated
with increased hallucination proneness. Moreover, using MRS it was shown that decreased
face-dependent activation in the FFA was related to lower glutamate levels. These
findings further substantiate theories that imply impaired glutamatergic neurotransmission
and a decreased ability to distinguish between noise and meaningful perceptual
information in the pathogenesis of hallucinations.Acknowledgements
No acknowledgement found.References
1. Kahn RS, Sommer IE, Murray RM, et al. Schizophrenia. Nat Rev Dis Primers 2015;1:15067.
2. DeRosse P,
Karlsgodt KH. Examining the Psychosis Continuum. Curr Behav Neurosci Rep
2015;2:80-89.
3. Bentall RP,
Slade PD. Reality testing and auditory hallucinations: a signal detection
analysis. The British journal of clinical psychology 1985;24 ( Pt 3):159-169.
4. Powers AR,
Mathys C, Corlett PR. Pavlovian conditioning-induced hallucinations result from
overweighting of perceptual priors. Science 2017;357:596-600.
5. Partos TR,
Cropper SJ, Rawlings D. You Don't See What I See: Individual Differences in the
Perception of Meaning from Visual Stimuli. PloS one 2016;11:e0150615.
6. Stuke H,
Kress E, Weilnhammer VA, Sterzer P, Schmack K. Overly strong priors for
socially meaningful visual signals in psychosis proneness. bioRxiv 2018:473421.
7. Howes O,
McCutcheon R, Stone J. Glutamate and dopamine in schizophrenia: an update for
the 21st century. J Psychopharmacol 2015;29:97-115.
8. Mekle R,
Schmack K, Fiebach JB, Stuke H. Pharmacologically increased dopamine levels
reduce GABA and glutamate concentrations in visual brain areas – a 1H
MRS study at 3T. ISMRM 27th Annual Meeting. Montreal, QC, Canada: International
Society of Magnetic Resonance in Medicine, 2019: 2257.
9. Mescher M,
Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral
editing and water suppression. NMR in biomedicine 1998;11:266-272.
10. Simpson R,
Devenyi GA, Jezzard P, Hennessy TJ, Near J. Advanced processing and simulation
of MRS data using the FID appliance (FID-A)-An open source, MATLAB-based
toolkit. Magn Reson Med 2017;77:23-33.
11. Provencher
SW. Estimation of metabolite concentrations from localized in vivo proton NMR
spectra. Magn Reson Med 1993;30:672-679.